Multiplexed diagnostics is the process of simultaneous detection of multiple biomarkers in a single sample. Multiplexed assays are gaining high acceptance in clinical diagnostic research as they provide benefit of analyzing several biomarkers simultaneously and with better predictive value than that with single analyte. Adoption of multiplexing methods in immunoassays, genomics and protein analysis are gaining potential application in the field of research while gathering acceptance in research, laboratory investigations.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/multiplexed-diagnostics-market.html
The global multiplexed diagnostics market is categorized as follows:
Application and products:
- Infectious disease diagnostics
- Pre/post natal genetic screening
- Oncology diagnostics
- Pharmcogenomics and other applications
- Identity diagnostics
- Forward-phase multiplexed immunoassays
- Reverse-phase multiplexed immunoassays
- Planar microarrays
- Bead‐based microarrays
At present, North America dominates the global multiplexed diagnostics market and is followed by Europe. Emerging economies of Asia-Pacific, Middle East and Latin America are also expected to undergo rapid growth in this market owing to benefits such as time saving and cost reduction in diagnostics.
Some of the major factors driving the market for multiplexed diagnostics include high demand for improving diagnosis and predicting treatment response. Other factors propelling the market growth are technological advances in multivariate diagnosis methods, continuous addition of novel and innovative biomarkers and an intensive effort to clinically validate these multiplexed diagnostic tests. However, dicey reimbursement policies, vague business models and ever increasing competition among the current market players may pose a challenge to the multiplexed diagnostics market.
Some of the key players contributing to the multiplexed diagnostics market include Abbott Laboratories, Inc., Agilent Technologies, Inc., BioMérieux SA, Bio-Rad Laboratories, Inc., ELITech Group, CytoCore, Inc., Life Technologies Corporation, Genzyme Corporation, GE Healthcare, Novartis Diagnostics, Hologic Inc., Illumina, Inc., MiraiBio, Inc., Myriad Genetics QIAGEN N.V, Roche Diagnostics, Quest Diagnostics Inc., Tecan Group Ltd. and Siemens Healthcare Diagnostics, Inc.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
More Reports On Medical Devices Market: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information.Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
90 State Street,
Albany NY – 12207